SCHEMBL5255141

SCHEMBL5255141

Brc1cc(OCc2ccccc2)cc2ccoc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.50
MAOB P27338 5/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 1/20 0.47
RHEB Q15382 1/20 0.45
MAOA P21397 2/20 0.45
MRGPRX4 Q96LA9 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
PIN1 Q13526 1/20 0.43
LMNA P02545 2/20 0.42
GAA P10253 1/20 0.42
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA4 P22748 2/20 0.42
CA7 P43166 2/20 0.42
CA9 Q16790 2/20 0.42
CA5A P35218 1/20 0.42
CA5B Q9Y2D0 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4898966 0.83 ALOX5 (0.59) ALOX5MAOBNPC1RAB9ARHEB
SCHEMBL29418792 0.83 ALOX5 (0.59) ALOX5MAOBNPC1RAB9ARHEB
SCHEMBL1562291 0.78 MAOB (0.60) ALOX5MAOBNPC1RAB9AMAOA
SCHEMBL4992573 0.78 MEN1 (0.47) ALOX5MAOBNPC1RAB9AMAOA
SCHEMBL12754483 0.77 MAOB (0.59) ALOX5MAOBRAB9ARHEBMAOA
SCHEMBL4087244 0.77 RHEB (0.52) ALOX5MAOBRHEBMRGPRX4MEN1
SCHEMBL24750130 0.75 MAOB (0.53) MAOBMAOAMRGPRX4
SCHEMBL28514685 0.75 CFD (0.50) PIN1
SCHEMBL31009359 0.75 MAOB (0.53) MAOBMAOAMRGPRX4
SCHEMBL5988383 0.75 MRGPRX4 (0.69) ALOX5MAOBNPC1RAB9AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487822-B1 PYRROLE-2,5-DIONE DERIVATIVES AND THEIR USE AS GSK-3 INHIBITORS LILLY CO ELI (US) 2007-08-01 EP disclosed
CN-1639152-A Pyrrole-2, 5-dione derivatives and their use as GSK-3 inhibitors LILLY CO ELI (US) 2005-07-13 CN disclosed